GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Valiant Laboratories Ltd (BOM:543998) » Definitions » Research & Development

Valiant Laboratories (BOM:543998) Research & Development : ₹0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Valiant Laboratories Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Valiant Laboratories's Research & Development for the three months ended in Dec. 2024 was ₹0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was ₹0 Mil.

Valiant Laboratories Research & Development Historical Data

The historical data trend for Valiant Laboratories's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valiant Laboratories Research & Development Chart

Valiant Laboratories Annual Data
Trend Mar21 Mar22 Mar23 Mar24
Research & Development
- - - -

Valiant Laboratories Quarterly Data
Mar21 Mar22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Valiant Laboratories Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Valiant Laboratories  (BOM:543998) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Valiant Laboratories Research & Development Related Terms

Thank you for viewing the detailed overview of Valiant Laboratories's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Valiant Laboratories Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Valiant Laboratories Ltd (BOM:543998) » Definitions » Research & Development
Comparable Companies
BOM:541400 BOM:526953 NSE:ACCENTMIC BOM:524731 BOM:530163 BOM:533543 BOM:540937 BOM:524075 BOM:532305 BOM:532649 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
VALIANTLAB:India
Address
Mulund Goregaon Link Road, 104, Udyog Kshetra, Mulund, MH, IND, 400080
Website
https://www.valiantlabs.in
Valiant Laboratories Ltd is an Active Pharmaceutical Ingredient (API)/Bulk Drug manufacturing company with having focus on manufacturing Paracetamol. Paracetamol is one of the widely used analgesics globally and is recommended as the first-line therapy in pain conditions by the World Health Organization. Paracetamol has several applications such as usage in the treatment of headaches, muscle aches, arthritis, backaches, toothaches, colds, and fever. It manufactures Paracetamol in various grades such as IP/BP/EP/USP, as per the pharmacopeia requirements of its customers.

Valiant Laboratories Headlines

No Headlines